UniProt ID | ODPA_HUMAN | |
---|---|---|
UniProt AC | P08559 | |
Protein Name | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | |
Gene Name | PDHA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 390 | |
Subcellular Localization | Mitochondrion matrix. | |
Protein Description | The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle.. | |
Protein Sequence | MRKMLAAVSRVLSGASQKPASRVLVASRNFANDATFEIKKCDLHRLEEGPPVTTVLTREDGLKYYRMMQTVRRMELKADQLYKQKIIRGFCHLCDGQEACCVGLEAGINPTDHLITAYRAHGFTFTRGLSVREILAELTGRKGGCAKGKGGSMHMYAKNFYGGNGIVGAQVPLGAGIALACKYNGKDEVCLTLYGDGAANQGQIFEAYNMAALWKLPCIFICENNRYGMGTSVERAAASTDYYKRGDFIPGLRVDGMDILCVREATRFAAAYCRSGKGPILMELQTYRYHGHSMSDPGVSYRTREEIQEVRSKSDPIMLLKDRMVNSNLASVEELKEIDVEVRKEIEDAAQFATADPEPPLEELGYHIYSSDPPFEVRGANQWIKFKSVS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | O-linked_Glycosylation | AAVSRVLSGASQKPA HHHHHHHHCCCCCCH | 29.47 | 22121020 | |
18 | Acetylation | VLSGASQKPASRVLV HHHCCCCCCHHEEEE | 39.80 | 63650805 | |
18 | Ubiquitination | VLSGASQKPASRVLV HHHCCCCCCHHEEEE | 39.80 | - | |
39 | Acetylation | NDATFEIKKCDLHRL CCCEEEEEECCHHHC | 39.90 | 2413493 | |
39 | Ubiquitination | NDATFEIKKCDLHRL CCCEEEEEECCHHHC | 39.90 | - | |
63 | Acetylation | LTREDGLKYYRMMQT EECHHHHHHHHHHHH | 45.85 | 25825284 | |
63 | Succinylation | LTREDGLKYYRMMQT EECHHHHHHHHHHHH | 45.85 | - | |
63 | Succinylation | LTREDGLKYYRMMQT EECHHHHHHHHHHHH | 45.85 | - | |
63 | Ubiquitination | LTREDGLKYYRMMQT EECHHHHHHHHHHHH | 45.85 | - | |
65 | Phosphorylation | REDGLKYYRMMQTVR CHHHHHHHHHHHHHH | 7.16 | 29496907 | |
77 | Acetylation | TVRRMELKADQLYKQ HHHHHHHCHHHHHHH | 36.29 | 23954790 | |
77 | Malonylation | TVRRMELKADQLYKQ HHHHHHHCHHHHHHH | 36.29 | 26320211 | |
77 | Succinylation | TVRRMELKADQLYKQ HHHHHHHCHHHHHHH | 36.29 | 27452117 | |
77 | Ubiquitination | TVRRMELKADQLYKQ HHHHHHHCHHHHHHH | 36.29 | - | |
83 | Acetylation | LKADQLYKQKIIRGF HCHHHHHHHHHHHHH | 54.42 | 23236377 | |
83 | Succinylation | LKADQLYKQKIIRGF HCHHHHHHHHHHHHH | 54.42 | 27452117 | |
83 | Ubiquitination | LKADQLYKQKIIRGF HCHHHHHHHHHHHHH | 54.42 | 19608861 | |
85 | Acetylation | ADQLYKQKIIRGFCH HHHHHHHHHHHHHHH | 35.63 | 23236377 | |
115 | Acetylation | INPTDHLITAYRAHG CCCCHHHHHHHHHCC | 1.53 | 19608861 | |
116 | Phosphorylation | NPTDHLITAYRAHGF CCCHHHHHHHHHCCC | 24.81 | - | |
118 | Phosphorylation | TDHLITAYRAHGFTF CHHHHHHHHHCCCEE | 10.32 | - | |
121 | Acetylation | LITAYRAHGFTFTRG HHHHHHHCCCEECCC | 23.93 | 19608861 | |
130 | Phosphorylation | FTFTRGLSVREILAE CEECCCCCHHHHHHH | 23.19 | 24719451 | |
139 | Phosphorylation | REILAELTGRKGGCA HHHHHHHHCCCCCCC | 26.84 | 20068231 | |
145 | S-palmitoylation | LTGRKGGCAKGKGGS HHCCCCCCCCCCCCC | 4.88 | 21044946 | |
152 | Phosphorylation | CAKGKGGSMHMYAKN CCCCCCCCCEEEEEE | 17.74 | - | |
156 | Phosphorylation | KGGSMHMYAKNFYGG CCCCCEEEEEEECCC | 10.35 | 29496907 | |
161 | Phosphorylation | HMYAKNFYGGNGIVG EEEEEEECCCCCCCC | 33.25 | 29496907 | |
168 | Phosphorylation | YGGNGIVGAQVPLGA CCCCCCCCCCCCCCC | 14.36 | 24719451 | |
227 | Phosphorylation | FICENNRYGMGTSVE EEECCCCCCCCCHHH | 17.37 | 26846344 | |
231 | Phosphorylation | NNRYGMGTSVERAAA CCCCCCCCHHHHHHC | 22.25 | 29255136 | |
232 | Dephosphorylation | NRYGMGTSVERAAAS CCCCCCCHHHHHHCC | 19.09 | 7782287 | |
232 | Phosphorylation | NRYGMGTSVERAAAS CCCCCCCHHHHHHCC | 19.09 | 29255136 | |
239 | Phosphorylation | SVERAAASTDYYKRG HHHHHHCCCCHHHCC | 19.65 | 28152594 | |
240 | Phosphorylation | VERAAASTDYYKRGD HHHHHCCCCHHHCCC | 24.24 | 28152594 | |
242 | Phosphorylation | RAAASTDYYKRGDFI HHHCCCCHHHCCCCC | 15.81 | 27273156 | |
243 | Phosphorylation | AAASTDYYKRGDFIP HHCCCCHHHCCCCCC | 9.30 | 28152594 | |
244 | Acetylation | AASTDYYKRGDFIPG HCCCCHHHCCCCCCC | 43.61 | 23236377 | |
244 | Malonylation | AASTDYYKRGDFIPG HCCCCHHHCCCCCCC | 43.61 | 26320211 | |
244 | Succinylation | AASTDYYKRGDFIPG HCCCCHHHCCCCCCC | 43.61 | - | |
244 | Succinylation | AASTDYYKRGDFIPG HCCCCHHHCCCCCCC | 43.61 | 27452117 | |
244 | Ubiquitination | AASTDYYKRGDFIPG HCCCCHHHCCCCCCC | 43.61 | - | |
245 | Methylation | ASTDYYKRGDFIPGL CCCCHHHCCCCCCCC | 33.52 | 115486777 | |
257 | Sulfoxidation | PGLRVDGMDILCVRE CCCCCCCEEEEEEEH | 2.21 | 21406390 | |
261 | Glutathionylation | VDGMDILCVREATRF CCCEEEEEEEHHHHH | 2.50 | 22555962 | |
269 | Phosphorylation | VREATRFAAAYCRSG EEHHHHHHHHHHHCC | 6.46 | 24719451 | |
272 | Phosphorylation | ATRFAAAYCRSGKGP HHHHHHHHHHCCCCC | 5.44 | 28152594 | |
273 | Glutathionylation | TRFAAAYCRSGKGPI HHHHHHHHHCCCCCE | 2.09 | 22555962 | |
275 | Phosphorylation | FAAAYCRSGKGPILM HHHHHHHCCCCCEEE | 41.10 | 21406692 | |
277 | Acetylation | AAYCRSGKGPILMEL HHHHHCCCCCEEEEE | 63.86 | 26051181 | |
277 | Succinylation | AAYCRSGKGPILMEL HHHHHCCCCCEEEEE | 63.86 | - | |
277 | Succinylation | AAYCRSGKGPILMEL HHHHHCCCCCEEEEE | 63.86 | - | |
277 | Ubiquitination | AAYCRSGKGPILMEL HHHHHCCCCCEEEEE | 63.86 | - | |
282 (in isoform 4) | Ubiquitination | - | 5.10 | - | |
286 | Phosphorylation | PILMELQTYRYHGHS CEEEEEEEEEECCCC | 23.69 | 26074081 | |
287 | Phosphorylation | ILMELQTYRYHGHSM EEEEEEEEEECCCCC | 9.01 | 26074081 | |
289 | Phosphorylation | MELQTYRYHGHSMSD EEEEEEEECCCCCCC | 11.18 | 22167270 | |
290 | Acetylation | ELQTYRYHGHSMSDP EEEEEEECCCCCCCC | 20.63 | 19608861 | |
293 | Dephosphorylation | TYRYHGHSMSDPGVS EEEECCCCCCCCCCC | 25.27 | 7782287 | |
293 | Phosphorylation | TYRYHGHSMSDPGVS EEEECCCCCCCCCCC | 25.27 | 20201521 | |
294 | Sulfoxidation | YRYHGHSMSDPGVSY EEECCCCCCCCCCCH | 4.34 | 28183972 | |
295 | Phosphorylation | RYHGHSMSDPGVSYR EECCCCCCCCCCCHH | 43.60 | 29255136 | |
300 | Dephosphorylation | SMSDPGVSYRTREEI CCCCCCCCHHCHHHH | 18.14 | 7782287 | |
300 | Phosphorylation | SMSDPGVSYRTREEI CCCCCCCCHHCHHHH | 18.14 | 22167270 | |
301 | Phosphorylation | MSDPGVSYRTREEIQ CCCCCCCHHCHHHHH | 17.38 | 22167270 | |
303 | Phosphorylation | DPGVSYRTREEIQEV CCCCCHHCHHHHHHH | 33.91 | 25884760 | |
305 | Acetylation | GVSYRTREEIQEVRS CCCHHCHHHHHHHHH | 59.86 | 19608861 | |
312 | Phosphorylation | EEIQEVRSKSDPIML HHHHHHHHCCCCEEH | 41.51 | 20068231 | |
313 | Acetylation | EIQEVRSKSDPIMLL HHHHHHHCCCCEEHH | 48.60 | 25825284 | |
313 | Malonylation | EIQEVRSKSDPIMLL HHHHHHHCCCCEEHH | 48.60 | 26320211 | |
313 | Succinylation | EIQEVRSKSDPIMLL HHHHHHHCCCCEEHH | 48.60 | - | |
313 | Succinylation | EIQEVRSKSDPIMLL HHHHHHHCCCCEEHH | 48.60 | - | |
313 | Ubiquitination | EIQEVRSKSDPIMLL HHHHHHHCCCCEEHH | 48.60 | - | |
314 | Phosphorylation | IQEVRSKSDPIMLLK HHHHHHCCCCEEHHH | 50.28 | 26471730 | |
318 | Sulfoxidation | RSKSDPIMLLKDRMV HHCCCCEEHHHHHHH | 4.34 | 21406390 | |
321 | Acetylation | SDPIMLLKDRMVNSN CCCEEHHHHHHHCCC | 39.05 | 19608861 | |
321 | Malonylation | SDPIMLLKDRMVNSN CCCEEHHHHHHHCCC | 39.05 | 26320211 | |
321 | Succinylation | SDPIMLLKDRMVNSN CCCEEHHHHHHHCCC | 39.05 | 27452117 | |
321 | Ubiquitination | SDPIMLLKDRMVNSN CCCEEHHHHHHHCCC | 39.05 | 19608861 | |
328 | Acetylation | KDRMVNSNLASVEEL HHHHHCCCCCCHHHH | 34.13 | 19608861 | |
331 | Phosphorylation | MVNSNLASVEELKEI HHCCCCCCHHHHHHC | 32.97 | 18691976 | |
333 | Phosphorylation | NSNLASVEELKEIDV CCCCCCHHHHHHCCH | 55.93 | 24719451 | |
336 | Acetylation | LASVEELKEIDVEVR CCCHHHHHHCCHHHH | 56.77 | 23954790 | |
336 | Ubiquitination | LASVEELKEIDVEVR CCCHHHHHHCCHHHH | 56.77 | - | |
338 | Phosphorylation | SVEELKEIDVEVRKE CHHHHHHCCHHHHHH | 7.41 | 24719451 | |
339 | Phosphorylation | VEELKEIDVEVRKEI HHHHHHCCHHHHHHH | 31.45 | 27251275 | |
341 | Phosphorylation | ELKEIDVEVRKEIED HHHHCCHHHHHHHHH | 32.62 | 27251275 | |
343 | Acetylation | KEIDVEVRKEIEDAA HHCCHHHHHHHHHHH | 19.86 | 19608861 | |
344 | Ubiquitination | EIDVEVRKEIEDAAQ HCCHHHHHHHHHHHH | 69.12 | - | |
354 | Ubiquitination | EDAAQFATADPEPPL HHHHHHHCCCCCCCH | 32.64 | 21890473 | |
359 | Acetylation | FATADPEPPLEELGY HHCCCCCCCHHHHCC | 44.13 | 19608861 | |
366 | Phosphorylation | PPLEELGYHIYSSDP CCHHHHCCEEECCCC | 9.54 | 28064214 | |
369 | Phosphorylation | EELGYHIYSSDPPFE HHHCCEEECCCCCCE | 6.71 | 18083107 | |
374 | Acetylation | HIYSSDPPFEVRGAN EEECCCCCCEECCCC | 42.92 | 19608861 | |
385 | Acetylation | RGANQWIKFKSVS-- CCCCCEEEEEECC-- | 43.72 | 23236377 | |
385 | Methylation | RGANQWIKFKSVS-- CCCCCEEEEEECC-- | 43.72 | 2401739 | |
385 | Succinylation | RGANQWIKFKSVS-- CCCCCEEEEEECC-- | 43.72 | - | |
385 | Succinylation | RGANQWIKFKSVS-- CCCCCEEEEEECC-- | 43.72 | - | |
385 | Ubiquitination | RGANQWIKFKSVS-- CCCCCEEEEEECC-- | 43.72 | - | |
392 | Ubiquitination | KFKSVS--------- EEEECC--------- | 21890473 | ||
392 | Ubiquitination | KFKSVS--------- EEEECC--------- | 21890473 | ||
392 | Ubiquitination | KFKSVS--------- EEEECC--------- | 21890473 | ||
423 | Ubiquitination | ---------------------------------------- ---------------------------------------- | 21890473 | ||
423 (in isoform 4) | Ubiquitination | - | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
232 | S | Phosphorylation | Kinase | PDHK1 | Q15118 | PSP |
232 | S | Phosphorylation | Kinase | PDK2 | Q15119 | GPS |
232 | S | Phosphorylation | Kinase | PDPK1 | O15530 | GPS |
289 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
293 | S | Phosphorylation | Kinase | PDHK1 | Q15118 | PSP |
293 | S | Phosphorylation | Kinase | PDHK2 | Q15119 | PSP |
293 | S | Phosphorylation | Kinase | PDHK3 | Q15120 | PSP |
293 | S | Phosphorylation | Kinase | PDHK4 | Q16654 | PSP |
293 | S | Phosphorylation | Kinase | PDPK1 | O15530 | GPS |
300 | S | Phosphorylation | Kinase | PDHK1 | Q15118 | PSP |
300 | S | Phosphorylation | Kinase | PDHK2 | Q15119 | PSP |
300 | S | Phosphorylation | Kinase | PDHK3 | Q15120 | PSP |
300 | S | Phosphorylation | Kinase | PDHK4 | Q16654 | PSP |
300 | S | Phosphorylation | Kinase | PDPK1 | O15530 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ODPA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
312170 | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-77; LYS-83; LYS-321 ANDLYS-336, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Structural basis for inactivation of the human pyruvate dehydrogenasecomplex by phosphorylation: role of disordered phosphorylationloops."; Kato M., Wynn R.M., Chuang J.L., Tso S.C., Machius M., Li J.,Chuang D.T.; Structure 16:1849-1859(2008). Cited for: X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 30-390, ENZYME REGULATION,AND PHOSPHORYLATION AT SER-232; SER-293 AND SER-300 BY PDK4. | |
"Phosphorylation of serine 264 impedes active site accessibility inthe E1 component of the human pyruvate dehydrogenase multienzymecomplex."; Seifert F., Ciszak E., Korotchkina L., Golbik R., Spinka M.,Dominiak P., Sidhu S., Brauer J., Patel M.S., Tittmann K.; Biochemistry 46:6277-6287(2007). Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 30-390, ENZYME REGULATION,AND PHOSPHORYLATION AT SER-293. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-300, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232 AND SER-293, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-293; SER-295AND SER-300, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232 AND SER-293, ANDMASS SPECTROMETRY. | |
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-231, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-231, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-289 AND TYR-301, ANDMASS SPECTROMETRY. |